Allouchery, Violette <br/><br/>
Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients.  [electronic resource] 

 -  Breast cancer research : BCR  05 2018 
 - 40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-542X 
<br/><br/><label>Standard No.: </label>10.1186/s13058-018-0968-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aromatase Inhibitors--administration & dosage<br/>Breast Neoplasms--blood<br/>Chemotherapy, Adjuvant--adverse effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Estrogen Receptor alpha--blood<br/>Female<br/>Humans<br/>Middle Aged<br/>Mutation<br/>Recurrence